Stem cells, organoids and cell models at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
18 organizations at Cell 2026 present work in stem cells, organoids and cell models: 9 drug developers, 5 suppliers and service providers and 4 academic, government and non-profit bodies. Between them they bring 29 presentations to the program. Most represented: AstraZeneca (4 on the program), INmune Bio (2 on the program), Rinri Therapeutics (2 on the program). As of Oct 8, 2026.
Format
Top represented
Showing 1–15 of 18 organizations
| Organization | Cell 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global drugmaker with medicines in oncology, cardiovascular, respiratory, immunology and rare disease, and a cell therapy pipeline. | Panel Thu Nov 12 12:25pm–12:50pm Cracking In Vivo Delivery For Next-Generation Gene Therapies Cell and gene therapy Panel Thu Nov 12 12:25pm–12:50pm The Productivity Challenge: How Can The Industry Deliver More Medicines With Less Manufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? Cell and gene therapy Talk Thu Nov 12 3:05pm–3:30pm Mapping Immune Vulnerabilities: CRISPR Screens for Target Discovery Stem cells, organoids and cell models Talk Fri Nov 13 3:10pm–3:35pm Cell Line Database Development Cell line developmentDigital biomanufacturing and AI Talk Fri Nov 13 3:50pm–4:15pm Clinical Trial Designs For Advanced Therapies Outside Of Oncology Cell and gene therapy Talk Fri Nov 13 4:15pm–4:40pm Reduction Of Animal Bi-Products In Cell Cultures Cell culture and upstream processing |
INmune Bio Boca Raton, Florida | |
Clinical-stage company developing immune-targeted therapies, including a TNF inhibitor for neurological disease and an umbilical cord MSC therapy. | Talk Thu Nov 12 9:25am–9:50am Designing Large Scale Cell Therapies For Real-World Access Cell and gene therapyManufacturing and CMC Panel Fri Nov 13 1:55pm–2:20pm Closing The Gap: Connecting Upstream And Downstream Bioprocessing In Cell-Based Therapies Cell culture and upstream processingCell and gene therapy Talk Fri Nov 13 4:40pm–5:05pm MSC Therapies: From Decades Of Challenges To Commercial Approval Cell and gene therapyStem cells, organoids and cell models |
Rinri Therapeutics Sheffield, UK | |
Clinical-stage company developing regenerative cell therapies for sensorineural hearing loss. | Talk Thu Nov 12 4:55pm–5:20pm Panel Thu Nov 12 5:45pm–6:10pm Panel Fri Nov 13 11:40am–12:05pm From Model To Medicine: Fixing The Translation Gap Stem cells, organoids and cell models |
UK-listed oncology drug developer that evaluates and develops early assets; its Inaphaea BioLabs unit supplies patient-derived cancer cell models. | Panel Fri Nov 13 11:40am–12:05pm From Model To Medicine: Fixing The Translation Gap Stem cells, organoids and cell models Talk Fri Nov 13 1:55pm–2:20pm Patient Derived Cells As New Approach Methodologies For More Predictive Oncology Models Stem cells, organoids and cell models |
a:head bio Vienna, Austria | |
Uses human brain organoid models to support neuroscience drug discovery. | Panel Fri Nov 13 11:40am–12:05pm From Model To Medicine: Fixing The Translation Gap Stem cells, organoids and cell models Talk Fri Nov 13 2:45pm–3:10pm Human Brain Organoids In Drug Discovery Stem cells, organoids and cell models |
MeiraGTx New York, New York | |
Clinical-stage gene therapy company with in-house viral vector manufacturing and programmes in eye, salivary gland and neurological disease. | Talk Fri Nov 13 9:25am–9:50am Human retinal organoids in gene therapy development Stem cells, organoids and cell modelsCell and gene therapy Panel Fri Nov 13 11:40am–12:05pm From Model To Medicine: Fixing The Translation Gap Stem cells, organoids and cell models |
Develops combination medicines pairing several mRNAs and siRNAs with its own delivery system and computational design, starting in lung fibrosis. | Talk Thu Nov 12 10:15am–10:40am Lost in Translation? Developing In Vitro Models That Better Predict Multi-RNA Therapeutics Stem cells, organoids and cell models Panel Thu Nov 12 12:25pm–12:50pm Cracking In Vivo Delivery For Next-Generation Gene Therapies Cell and gene therapy |
Eppendorf Hamburg, Germany | Presentation & exhibition package |
Makes lab equipment and bioprocess systems, including single-use bioreactors and control software for cell culture and fermentation. | Talk Thu Nov 12 3:30pm–3:55pm LARGE-SCALE PRODUCTION OF HUMAN PLURIPOTENT STEM CELL DERIVED CARDIOMYOCYTES Stem cells, organoids and cell modelsCell culture and upstream processing |
HT Helene Therapeutics | |
Talk Fri Nov 13 5:05pm–5:30pm Exploring The Future Of Autologous Stem Cell Therapy Cell and gene therapyStem cells, organoids and cell models | |
Hungarian Academy of Sciences Budapest, Hungary | |
Hungary's national academy of sciences, a learned society linked to a network of research institutes. | Talk Fri Nov 13 3:50pm–4:15pm Stem Cell-Derived Organoid Research Supporting Advanced Therapies Stem cells, organoids and cell modelsCell and gene therapy |
M MHRA London, UK | |
UK regulator of medicines, medical devices and blood products, which also sets biological reference standards. | Talk Fri Nov 13 5:30pm–5:55pm Development Of A WHO Approved Phenotypic Flow Standard For Mesenchymal Stromal Cells Analytics and characterizationStem cells, organoids and cell models |
Plasticell Stevenage, UK | |
Develops cell therapies, including iPSC-derived immune cells, using combinatorial screening of stem cell culture conditions. | Talk Fri Nov 13 3:50pm–4:15pm Advances in manufacturing of iPSC derived NK cells for immunotherapy Cell and gene therapyStem cells, organoids and cell models |
University of Kent Canterbury, UK | |
Public university whose School of Biosciences researches recombinant protein production in cells, cell biology and neuroscience. | Panel Thu Nov 12 10:15am–10:40am What’s Next For Cell And Stem Cell Therapies? Challenges, Opportunities, And Clinical Translation Cell and gene therapyStem cells, organoids and cell models |
University of Minho Braga, Portugal | |
Portuguese public university whose health sciences research includes the stem cell secretome in nervous system injury and repair. | Talk Fri Nov 13 4:15pm–4:40pm Modulatory Action of Stem Cells Secretome in Injury and Degeneration of the Central Nervous System Stem cells, organoids and cell models |
◇Bronze Sponsor | |
PHC Group lab equipment maker whose cell analysis line includes a live cell metabolic analyser, live cell imaging and automated cell expansion. | Talk Thu Nov 12 12:50pm–1:15pm |
Instantly find 20 buyers in stem cells, organoids and cell models
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Cell 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction